Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM66E is a long non-coding RNA (lncRNA) gene, annotated primarily from sequence similarity among gene families, and indexed in gene databases for reference (HGNC: 18735, NCBI Gene: 100132103, Ensembl: ENSG00000225725, UniProtKB/Swiss-Prot: P0C841)[4]. It does not encode a protein, nor is it classified among enzymes, receptors, channels, or other typical drug targets. There is currently no reported biological function or disease role specific to FAM66E. Its listing in target databases may arise from nomenclature confusion or incomplete annotation; care should be taken when considering it as a protein or therapeutic target. No interacting drugs, mechanism of action data, biomarker usage, or safety concerns are described for FAM66E. As a member of the lncRNA family, its biological properties and significance remain largely uncharacterized[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 66 member E (FAM66E).